Metraipolis › archive › dc_6cdfaa64fc7d

Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database — Europe PMC PMID:42058112

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42058112
DOI
10.1515/med-2026-1416
License (as archived)
solo-consultazione
Archived
2026-11-07T04:15:34.622Z
SHA-256 of the archived text
88b180882f388e6872d1adf7629a3d53a915f1800801d4e6915dbde45d907aca
Stable URL of this page
https://metraipolis.com/documento/dc_6cdfaa64fc7d

How to cite

Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database — Europe PMC PMID:42058112 — Europe PMC (en), https://europepmc.org/article/MED/42058112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6cdfaa64fc7d (Metraipolis archive dc_6cdfaa64fc7d, sha256 88b180882f388e6872d1adf7629a3d53a915f1800801d4e6915dbde45d907aca)
BibTeX
@misc{dc6cdfaa64fc7d,
  title = {Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database — Europe PMC PMID:42058112},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42058112},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6cdfaa64fc7d; sha256 88b180882f388e6872d1adf7629a3d53a915f1800801d4e6915dbde45d907aca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42058112. Agents can read the archived copy with the MCP tool read_document.